Skip to content

Hospital Innovation Programs Directory

An independent editorial resource published by Lisa T. Miller

Menu

Healthcare company-building profile

Bear's Den

Hackensack Meridian Health

AcceleratorHealth system acceleratorHospital or health systemActive

Source-based profile

Program at a Glance

Program type
Accelerator
Program category
Health system accelerator
Organization
Hackensack Meridian Health
Organization type
Hospital or health system
Location
Edison, New Jersey
Company stage served
Not publicly documented
Cohort or participation model
Not publicly documented
Investment or funding offered
Not publicly documented
Published investment terms
Not publicly documented
Equity or fee model
Not publicly documented
Clinical or hospital connection
Yes
Application status
Active
Founded
2017

Public description

About the program

Bear's Den is Hackensack Meridian Health's innovation and investment program, launched in 2017, that convenes quarterly panels to evaluate healthcare ideas and inventions from entrepreneurs, venture capitalists, partners and the system's own 36,000 team members. Selected concepts receive strategic partnerships, funding and other support, and external companies can receive direct equity investment from the health network. Hackensack Meridian has used a dedicated fund to make these investments, including a $25 million vehicle reported in 2018. The internal track has produced clinical and operational improvements sourced from nurses, physicians and frontline staff across the network's hospitals. It functions as both an accelerator for outside companies and an internal idea-funding mechanism.

What the program publicly emphasizes

Focus areas and features

Venture fundEntrepreneurshipPhysician innovationNursing innovation
  • Category: Health system accelerator

Publicly documented people and network

Program leadership and alumni

Program leader
Sandra Powell-Elliott — Vice President and Chief Innovation and Commercialization Officer
Notable alumni named in public materials
Used a reported $25 million fund to invest in Pillo Health in 2018; made an equity investment in Alloplex Biotherapeutics; a single 2022 internal cycle drew more than 100 submissions and funded six winning team-member ideas spanning ICU cable management, medication reconciliation, pressure injury prevention, opioid-reduction ERAS protocols, ICU early mobilization and barcoding of tube-fed nutritional supplements

Sources

External source links open in a new tab.

  1. hackensackmeridianhealth.org
  2. medcitynews.com
  3. alloplexbio.com